NCT04210492View on ClinicalTrials.gov

Dose-Deescalated 3-Fraction Stereotactic Body Radiotherapy For Centrally Located Lung Cancer

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

August 26, 2020

Primary Completion Date

January 31, 2030

Study Completion Date

January 31, 2030

Conditions
Non-small Cell Lung Cancer
Interventions
RADIATION

45 Gray (Gy) regimen

Deescalated 3-fraction stereotactic body radiotherapy regimen to 45 Gy in 3 fractions.

Trial Locations (6)

06830

RECRUITING

Smilow Cancer Hospital Care Center at Greenwich, Greenwich

06437

RECRUITING

Smilow Cancer Hospital Care Center - Guilford, Guilford

06518

RECRUITING

Smilow Cancer Hospital - Hamden Care Center, Hamden

06511

RECRUITING

Smilow Cancer Hospital, New Haven

06611

RECRUITING

Smilow Cancer Hospital Care Center - Trumbull, Trumbull

06385

RECRUITING

Smilow Cancer Hospital Care Center - Waterford, Waterford

All Listed Sponsors
lead

Yale University

OTHER